SCHEMBL28031076

SCHEMBL28031076

NC(=O)COc1ccccc1[C]=O

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.57
KDM4E B2RXH2 2/20 0.57
SMN1; SMN2 Q16637 5/20 0.51
GAA P10253 2/20 0.51
MAPK1 P28482 1/20 0.47
PTGDR2 Q9Y5Y4 2/20 0.46
POLB P06746 1/20 0.43
ALDH1A1 P00352 2/20 0.42
HPGD P15428 1/20 0.42
TSHR P16473 1/20 0.42
CASP1 P29466 1/20 0.42
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
TP53 P04637 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
ATM Q13315 1/20 0.40
GLA P06280 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
BCL2A1 Q16548 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2221490 0.84 SMN1; SMN2 (0.70) HTTKDM4ESMN1; SMN2GAAMAPK1
SCHEMBL5362778 0.82 HTT (0.71) HTTKDM4ESMN1; SMN2GAAPOLB
SCHEMBL14919231 0.82 KMT2A (0.48) KDM4ESMN1; SMN2GAAMAPK1PTGDR2
SCHEMBL8577079 0.79 TDP1 (0.59) HTTSMN1; SMN2MAPK1PTGDR2ALDH1A1
SCHEMBL6538778 0.79 ALDH1A1 (0.57) HTTKDM4ESMN1; SMN2GAAMAPK1
SCHEMBL10420902 0.77 PTGDR2 (0.40) KDM4ESMN1; SMN2GAAMAPK1PTGDR2
SCHEMBL6539052 0.77 USP2 (0.56) KDM4ESMN1; SMN2MAPK1ALDH1A1HPGD
SCHEMBL5520675 0.76 SMN1; SMN2 (0.72) HTTKDM4ESMN1; SMN2POLBHPGD
SCHEMBL5214442 0.76 HTT (0.62) HTTKDM4ESMN1; SMN2GAAPOLB
SCHEMBL1933278 0.76 GAA (0.63) HTTKDM4ESMN1; SMN2GAAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107674077-A 8 [base of 3 amino piperidine 1] Xanthine compounds, its preparation method and purposes as pharmaceutical preparation 勃林格殷格翰制药两合公司 2018-02-09 CN disclosed
CN-105001222-B 8 [base of 3 amino piperidine 1] Xanthine compounds, its preparation method and purposes as pharmaceutical preparation 勃林格殷格翰制药两合公司 2017-11-07 CN disclosed
CN-102964347-B 8-[3-amino-piperadine-1-base]-Xanthine compounds, its preparation method and the purposes as pharmaceutical preparation BOEHRINGER INGELHEIM PHARMACEUTICAL CO., LTD. (DE) 2015-11-18 CN disclosed
CN-105001222-A New 8-(3-amino-piperidin-1-yl)-xanthine derivatives, preparing method and uses thereof as a pharmaceutic preparation BOEHRINGER INGELHEIM PHARMA 2015-10-28 CN disclosed